Actively Recruiting

All Genders
NCT06655090

Fibrotic Interstitial Lung Disease Early Recognition and Strategic Therapy Study in China

Led by Dai Huaping · Updated on 2024-10-23

10000

Participants Needed

1

Research Sites

312 weeks

Total Duration

On this page

Sponsors

D

Dai Huaping

Lead Sponsor

T

The First Affiliated Hospital of Guangzhou Medical University

Collaborating Sponsor

AI-Summary

What this Trial Is About

This project aimed to: 1) construct a cohort of no less than 10000 cases of f-ILD (including pneumoconiosis ≥3000 cases) with continuous regular follow-up to reveal the clinical phenotypes closely related to the development, progression and prognosis of pulmonary fibrosis; 2) systematically evaluate the safety and effectiveness of frozen lung biopsy, surgical lung biopsy/thoracoscopic lung biopsy and other techniques, and to optimize the histological diagnosis method of f-ILD; 3) construct a set of artificial intelligence (AI) evaluation system for quantitative evaluation of pulmonary fibrosis and its severity, and develop application software; 4) excavate and verify important molecular targets for the formation of pulmonary fibrosis and identify biomarkers; 5) combined with clinical phenotype, imaging, pathology and biomarkers to establish f-ILD early recognition and progress model, intervention strategies, guidelines and consensus, and applicated nationwide.

CONDITIONS

Official Title

Fibrotic Interstitial Lung Disease Early Recognition and Strategic Therapy Study in China

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed as ILD
Not Eligible

You will not qualify if you...

  • Lack of chest CT
  • Patients refused to participant

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

China-Japan Friendship Hospital

Beijing, Beijing Municipality, China, 100029

Actively Recruiting

Loading map...

Research Team

H

Huaping Dai, M.D. Ph.D.

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Fibrotic Interstitial Lung Disease Early Recognition and Strategic Therapy Study in China | DecenTrialz